PharmaSource: The External Manufacturing Community

Your Biopharma Outsourcing Intelligence Hub

Trusted by 50,000+ biopharma manufacturing professionals Sign up for Newsletter

Cytovance Biologics Launches Cell Line Development Services for Mammalian Programs

Scinai Immunotherapeutics Reports Q1 2026 Results Following Recipharm Israel Deal

FibroFind Appoints Co-Founder Lee Borthwick as CEO as Preclinical CRO Doubles in Size and Expands Leadership Team

Resilience, Risk & Relationships – ExM Leaders Report

Symeres Expands Spray Drying Capabilities at New Jersey CMC Site

Axplora Consolidates UDCA Manufacturing at Vizag Site by End of 2026

Chime Biologics Expands Manufacturing Capacity With New GMP-2 Facility

Chime Biologics Partners With Daewoong Pharmaceutical on Dupilumab Biosimilar

Matica Biotechnology Partners With UHN on IL-10 Adenoviral Gene Therapy Manufacturing

VIVEbiotech Expands In Vivo Gene Therapy Portfolio to 15 Programs

Gaelic Laboratories Completes Phase 1 Integration With Athlone Laboratories

Scinai Immunotherapeutics Reports Q1 2026 Results Following Recipharm Israel Deal

FibroFind Appoints Co-Founder Lee Borthwick as CEO as Preclinical CRO Doubles in Size and Expands Leadership Team

Resilience, Risk & Relationships – ExM Leaders Report

PODCASTS

How Sanofi Navigates Regulatory CMC Across Global Markets: Insights from Manda Pasarkar

The Politics Behind the Pipeline: How MFN Pricing and Tariffs Are Reshaping Pharma’s Global Strategy

SPOTLIGHT

Why Compliance-Driven CDMOs Win Sponsor Contracts

RESOURCES

Resilience, Risk & Relationships – ExM Leaders Report

[DOWNLOAD] Partnerships for an Uncertain World: The CDMO Live Europe 2026 Report

Resilience, Risk & Relationships – ExM Leaders Report

UPCOMING EVENTS

External Manufacturing Leaders Basel 2026

CDMO Live Europe 2027

CDMO Live Americas 2026

PharmaSource: The External Manufacturing Community

Cytovance Biologics Launches Cell Line Development Services for Mammalian Programs

Cytovance Biologics Launches Cell Line Development Services for Mammalian Programs

Scinai Immunotherapeutics Reports Q1 2026 Results Following Recipharm Israel Deal

FibroFind Appoints Co-Founder Lee Borthwick as CEO as Preclinical CRO Doubles in Size and Expands Leadership Team

Resilience, Risk & Relationships – ExM Leaders Report

Symeres Expands Spray Drying Capabilities at New Jersey CMC Site

Axplora Consolidates UDCA Manufacturing at Vizag Site by End of 2026

Chime Biologics Expands Manufacturing Capacity With New GMP-2 Facility

Chime Biologics Partners With Daewoong Pharmaceutical on Dupilumab Biosimilar

Matica Biotechnology Partners With UHN on IL-10 Adenoviral Gene Therapy Manufacturing

VIVEbiotech Expands In Vivo Gene Therapy Portfolio to 15 Programs

Gaelic Laboratories Completes Phase 1 Integration With Athlone Laboratories

Scinai Immunotherapeutics Reports Q1 2026 Results Following Recipharm Israel Deal

FibroFind Appoints Co-Founder Lee Borthwick as CEO as Preclinical CRO Doubles in Size and Expands Leadership Team

Resilience, Risk & Relationships – ExM Leaders Report

How Sanofi Navigates Regulatory CMC Across Global Markets: Insights from Manda Pasarkar

The Politics Behind the Pipeline: How MFN Pricing and Tariffs Are Reshaping Pharma’s Global Strategy

Why Compliance-Driven CDMOs Win Sponsor Contracts

Resilience, Risk & Relationships – ExM Leaders Report

[DOWNLOAD] Partnerships for an Uncertain World: The CDMO Live Europe 2026 Report

Resilience, Risk & Relationships – ExM Leaders Report

External Manufacturing Leaders Basel 2026

CDMO Live Europe 2027

CDMO Live Americas 2026

Welcome to PharmaSource

Follow us

Top Links

Get in touch